Analysis of short-term change in subfoveal choroidal thickness in eyes with age-related macular degeneration using optical coherence tomography

Ophthalmic Surgery Lasers and Imaging Retina

Volumn 45, Issue 1, 2014, Pages 32-37

  Fein, Jordana G ^a   Branchini, Lauren A ^a   Manjunath, Varsha ^a   Regatieri, Caio V ^a,b   Fujimoto, James G ^c   Duker, Jay S ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; PEGAPTANIB; TRIAMCINOLONE; ANGIOGENESIS INHIBITOR;

ADULT; AGED; COHORT ANALYSIS; COMPUTER PROGRAM; CONFERENCE PAPER; DISEASE SEVERITY; DRUSEN; EYE; FEMALE; FOLLOW UP; GEOGRAPHIC ATROPHY; HUMAN; MACULAR THICKNESS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBSERVATIONAL STUDY; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; RETROSPECTIVE STUDY; SUBFOVEAL CHOROIDAL THICKNESS; SUBRETINAL FLUID; SUBRETINAL NEOVASCULARIZATION; VERY ELDERLY; ARTICLE; CHOROID; EXUDATIVE MACULAR DEGENERATION; ORGAN SIZE; PATHOLOGY; RETINA FOVEA; MEDICAL RECORD REVIEW; NEOVASCULARIZATION (PATHOLOGY);

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; CHOROID; FEMALE; FOLLOW-UP STUDIES; FOVEA CENTRALIS; GEOGRAPHIC ATROPHY; HUMANS; MALE; MIDDLE AGED; ORGAN SIZE; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; WET MACULAR DEGENERATION;

EID: 84892600488     PISSN: 23258160     EISSN: 23258179     Source Type: Journal    
DOI: 10.3928/23258160-20131220-04     Document Type: Conference Paper

References (30)

1. Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science. 1991; 254(5035): 1178-1181. (Pubitemid 21917444)
2. Drexler W, Fujimoto JG. State-of-The-art retinal optical coherence tomography. Prog Retina Eye Res. 2008; 27(1): 45-88. (Pubitemid 351165776)
3. Potsaid B, Gorczynska I, Srinivasan VJ, et al. Ultrahigh speed spectral / Fourier domain OCT ophthalmic imaging at 70,000 to 312,500 axial scans per second. Opt Express. 2008; 16(19): 15149-169.
4. Sander B, Larsen M, Thrane L, et al. Enhanced optical coherence tomography imaging by multiple scan averaging. Br J Ophthalmol. 2005; 89(2): 207-212. (Pubitemid 40175220)
5. Ferguson RD, Hammer DX, Paunescu LA, Beaton S, Schuman JS. Tracking optical coherence tomography. Opt Lett. 2004; 29(18): 2139-2141.
6. Spaide RF, Koizumi H, Pozzoni MC. Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol. 2008; 146(4): 496-500.
7. Imamura Y, Fujiwara T, Margolis R, Spaide RF. Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy. Retina. 2009; 29(10): 1469-1473.
8. Fujiwara T, Imamura Y, Margolis R, Slakter JS, Spaide RF. Enhanced depth imaging optical coherence tomography of the choroid in highly myopic eyes. Am J Ophthalmol. 2009; 148(3): 445-450.
9. Spaide RF. Age-related choroidal atrophy. Am J Ophthalmol. 2009; 147(5): 801-810.
10. Manjunath V, Goren J, Fujimoto J, Duker JS. Analysis of Choroidal thickness in Age-Related Macular Degeneration Using Spectral-Domain Optical Coherence Tomography. Am J Ophthalmol. 2011; 152(4): 663-668.
11. Congdon N, O'Colmain B, Klaver CC, et al. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 2004; 122(4): 477-485. (Pubitemid 38456282)
12. Li Y, Xu L, Wang YX, You QS, Yang H, Jonas JB. Prevalence of age-related maculopathy in the adult population in China: the Beijing eye study. Am J Ophthalmol. 2006; 142(5): 788-793.
13. Kaiser PK, Blodi BA, Shapiro H, Acharya NR; MARINA Study Group. Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration. Ophthalmology. 2007; 114(10): 1868-1875.
14. Spaide RF. Enhanced depth imaging optical coherence tomography of retinal pigment epithelial detachment in age-related macular degeneration. Am J Ophthalmol. 2009; 147(4): 644-652.
15. Koizumi H, Yamagishi T, Yamazaki T, Kawasaki R, Kinoshita S. Subfoveal choroidal thickness in typical age-related macular degeneration and polypoidal choroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol. 2011; 249(8): 1123-1128.
16. Chung SE, Kang SW, Lee JH, Kim YT. Choroidal thickness in polypoidal choroidal vasculopathy and exudative age-related macular degeneration. Ophthalmology. 2011; 118(5): 840-845.
17. Manjunath V, Taha M, Fujimoto JG, Duker JS. Choroidal thickness in normal eyes measured using Cirrus HD optical coherence tomography. Am J Ophthalmol. 2010; 150(3): 325-329.
18. Adamis AP, Shima DT. The role of vascular endothelial growth factor in ocular health and disease. Retina. 2005; 25(2): 111-118. (Pubitemid 40365933)
19. Forte R, Cennamo G, Breve MA, Vecchio EC, de Crecchio G. Functional and Anatomic Response of the Retina and the Choroid to Intravitreal Bevacizumab for Macular Edema. J Ocul Pharmacol Ther. 2012; 28(1): 69-75.
20. Kiel JW. Modulation of choroidal autoregulation in the rabbit. Exp Eye Res. 1999; 69(4): 413-429. (Pubitemid 29469909)
21. Kiel JW, Shepherd AP. Autoregulation of choroidal blood flow in the rabbit. Invest Ophthalmol Vis Sci. 1992; 33(8): 2399-2410.
22. Kiel JW, van Heuven WA. Ocular perfusion pressure and choroidal blood flow in the rabbit. Invest Ophthalmol Vis Sci. 1995; 36(3): 579-585.
23. Reiner A, Zagvazdin Y, Fitzgerald ME. Choroidal blood flow in pigeons compensates for decreases in arterial blood pressure. Exp Eye Res. 2003; 76(3): 273-282. (Pubitemid 36263326)
24. Chakraborty R, Read SA, Collins MJ. Diurnal Variations in Axial Length, Choroidal Thickness, Intraocular Pressure, and Ocular Biometrics. Invest Ophthalmol Vis Sci. 2011; 52(8): 5121-5129.
25. Margolis R, Spaide RF. A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes. Am J Opthalmol. 2009; 147(5): 811-815.
26. Marneros AG, Fan J, Yokoyama Y, et al. Vascular endothelial growth factor expression in the retinal pigment epithelium is essential for choriocapillaris development and visual function. Am J Pathol. 2005; 167(5): 1451-1459. (Pubitemid 41541430)
27. Nishijima K, Nh YS, Zhong L, et al. Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury. Am J Pathol. 2007; 171(1): 53-67. (Pubitemid 47339226)
28. Brown DM, Michels M, Kaiser PK, et al. Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study. Ophthalmology. 2009; 116(1): 57-65.
29. McBain VA, Kumari R, Townend J, Lois N. Geographic atrophy in retinal angiomatous proliferation. Retina. 2011; 31(6): 1043-1052.
30. Rahman W, Chen FK, Yeoh J, da Cruz L. Enhanced depth imaging of the choroid in patients with neovascular age-related macular degeneration treated with anti-VEGF therapy versus untreated patients. Graefes Arch Clin Exp Ophthalmol. 2013; 251(6): 1483-1488.